Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)

CUSIP: 640979100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
181,633,257
Total 13F shares
36,353,167
Share change
+36,353,167
Total reported value
$512,042,809
Price per share
$14.11
Number of holders
38
Value change
+$512,042,809
Number of buys
38

Quarterly Holders Quick Answers

What is CUSIP 640979100?
CUSIP 640979100 identifies NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AMGEN INC
3/4/5
10%+ Owner —
class O/S missing
35,368,653
 $423,716,463 — 19 Sep 2023
3/4/5
FMR LLC
3/4/5
Other* —
class O/S missing
5,624,353
 $67,379,749 — 19 Sep 2023
3/4/5

Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q3 2023

As of 30 Sep 2023, Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,353,167 shares. The largest 10 holders included SOFTBANK GROUP CORP., FMR LLC, MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Artal Group S.A., CITADEL ADVISORS LLC, EcoR1 Capital, LLC, Avidity Partners Management LP, HHLR ADVISORS, LTD., and ORBIMED ADVISORS LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q4 2025 Across Filers

Q4 2025 holders
100
Q3 2023 holders
38
Holder diff
-62
Investor Q4 2025 Shares Q3 2023 Shares Share Diff Share Chg % Q4 2025 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .